Journal of Emergency Health Care
Formerly known as: International Journal of Medical Investigation
Volume 11, Issue 2 (7-2022)
J Emerg Health Care 2022, 11(2): 183-190 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zandian H, Ardekani A M, Zamaniahari U. Comparison Of Total Antioxidant Capacity (Tac) Of Saliva In Patients With Type 1 Diabetes Compared To Non-Diabetics Patients. J Emerg Health Care 2022; 11 (2) :183-190
URL: http://intjmi.com/article-1-879-en.html
URL: http://intjmi.com/article-1-879-en.html
–Social Determinants Of Health Research Center, Ardabil University Of Medical Sciences, Ardabil, Iran
Abstract: (1716 Views)
Introduction and objectives: Oxidative stress plays a crucial role in the onset and also the progression of vascular and neurological complications of diabetes. The present study was aimed to determine and compare the antioxidant capacity of saliva in patients with type 1 diabetes compared with those do not have diabetic.
Materials and methods: In this case-control study, the patients aged 20-40 years referred to Imam Khomeini Hospital in Ardabil were categorized into two groups including 30 patients with type 1 diabetes as a case group and 30 non-diabetics as a control group. These two groups were compared in terms of TAC levels in saliva. The TAC of saliva the patients measured by 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) method. The analysis of data was carried out through t-test statistic using "SPSS Statistics Version 24" at a significant level of P <0.05.
Results: Based on the data achieved from the present study, the mean and standard deviation of TAC of saliva in patients with type 1 diabetes was 0.380 ± 0.120 (μmol / l) and in non-diabetics was 0.306 ± 0.122 (μmol / l). The increment of TAC of saliva in the case group compared to the control group was significant based on T-test (p = 0.003).
Conclusion: Since there is a significant increment in the level of TAC of saliva in patients with type 1 diabetes compared to non-diabetics, the determination of the level of TAC of saliva in patients with type 1 diabetic can be used as an alternative method for early diagnosis of diabetes.
Materials and methods: In this case-control study, the patients aged 20-40 years referred to Imam Khomeini Hospital in Ardabil were categorized into two groups including 30 patients with type 1 diabetes as a case group and 30 non-diabetics as a control group. These two groups were compared in terms of TAC levels in saliva. The TAC of saliva the patients measured by 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) method. The analysis of data was carried out through t-test statistic using "SPSS Statistics Version 24" at a significant level of P <0.05.
Results: Based on the data achieved from the present study, the mean and standard deviation of TAC of saliva in patients with type 1 diabetes was 0.380 ± 0.120 (μmol / l) and in non-diabetics was 0.306 ± 0.122 (μmol / l). The increment of TAC of saliva in the case group compared to the control group was significant based on T-test (p = 0.003).
Conclusion: Since there is a significant increment in the level of TAC of saliva in patients with type 1 diabetes compared to non-diabetics, the determination of the level of TAC of saliva in patients with type 1 diabetic can be used as an alternative method for early diagnosis of diabetes.
Keywords: Diabetes, Antioxidants, Oxidative stress, Saliva, Total antioxidant capacity (TAC) of saliva
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |